Tip: Rotate injection sites, use an OTC hydrocortisone cream for irritation, or adjust injection frequency if needed
Science Spyglass GLP-1 receptor assay: drug discovery in the metabolic disorders field Metabolic disorders , particularly type 2 diabetes and obesity , represent a major global health burden
In favor of their argument, genetic deficiency of myostatin in humans increases muscle mass with no obvious deleterious phenotypes
Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [939] as a GLP-1 receptor antagonist
Nausea Diarrhea Vomiting Decreased appetite Constipation Mild stomach discomfort Heartburn These reactions are similar to what users of other GLP-1 based treatments experience
Rapid improvement in glycaemic control may worsen diabetic retinopathy in some patients with type 2 diabetes